The Military Is About to Screen Every Man Over 30 for Low Testosterone. Here's What That Means for VA Claims Down the Road.
A July 2026 order makes testosterone screening mandatory at every annual health assessment for troops 30 and up, with voluntary TRT to follow. Whatever you think of the policy, it's about to generate a mountain of medical evidence, and evidence is what claims are made of.

On July 15, 2026, the Secretary of War signed a memo titled "Health and Human Performance Optimization to Enhance Military Readiness." The short version: every service member 30 and older now gets an annual testosterone screening as part of their Periodic Health Assessment, younger troops can opt in, and members whose results and evaluation support it can choose testosterone replacement therapy, voluntarily, through military medicine.
The policy has its cheerleaders and its critics, and we're not here to referee that fight. We're here for the question nobody's answering yet: what does a force-wide hormone screening program mean for VA disability claims five, ten, twenty years from now? Because whatever else this order does, it's about to do something the claims world should pay attention to. It's going to document things.
What the order actually does
The facts first, without spin. Screening is mandatory at 30 and up, annual, and built into the PHA. Under 30 it's voluntary. A low result doesn't automatically mean treatment; it triggers evaluation, and TRT is offered as a choice when military physicians recommend it. That's the policy as announced. Plenty of details remain unanswered, including how the data will be recorded and used, and, the one that matters most for this post, whether a service member who starts TRT in uniform is assured continued therapy through the VA after discharge. As of now, nobody has said.
Why this matters for claims: the documentation effect
Here's the thing veterans law teaches you about any new military-wide medical program: the policy debate fades, the records remain. Every claim runs on three elements, and the one veterans struggle with most is proving what happened, or what was found, in service. A force-wide annual screening changes that math for an entire category of conditions.
Starting now, hundreds of thousands of service records will contain annual, objective hormone data. A veteran who separates in 2032 with documented in-service testosterone deficiency won't have to reconstruct it from memory; it'll be in the file, year over year, with the military's own numbers. If that deficiency, or anything downstream of it, becomes a claim later, the in-service element is already built. That's not a small thing. It's the kind of evidence veterans of earlier eras spend years trying to assemble.
The practical takeaway for anyone still serving: treat every screening result like the claims evidence it may become. Get copies, keep them, and if a result is abnormal, make sure the follow-up evaluation happens and gets documented too. Silent gaps in medical records are the oldest claim-killer there is.
The conditions this could touch
A few places where this program may eventually intersect the claims system, stated carefully, because some of this is projection rather than settled law.
Hypogonadism itself. Diagnosed testosterone deficiency connected to service can already be claimed, and related conditions have rating and special monthly compensation implications that are worth understanding case by case. Systematic screening means systematic diagnosis, which likely means more of these claims, better documented.
The underlying causes. Here's the part clinicians keep pointing out about screening at 30: low testosterone at that age usually has a driver, and the drivers read like a list of common service-connected conditions. Sleep disorders, including apnea. Chronic pain and the medications that treat it. Obesity, traumatic brain injury, and pituitary dysfunction that can follow it. Mental health conditions and their medications. Which means an abnormal screen may function as a flare in the sky, pointing toward an undiagnosed condition that is itself claimable. A veteran whose low-T workup surfaces sleep apnea has just documented two conditions, not one.
TRT itself, and what follows it. For members who start therapy, the long arc is unwritten. TRT is typically ongoing once started, its risk profile over decades is still being studied, and the continuity question, whether the VA picks up a therapy the military started, is officially unanswered. If history is a guide, programs the military runs at scale eventually generate claims the VA has to reckon with, and the veterans who documented everything fare best when that reckoning comes.
The honest caveats
None of this is a gold rush, and anyone selling it that way should be ignored. Screening data is evidence, not entitlement; a number in a file still needs a diagnosis, and a diagnosis still needs a connection to service, and conditions that predate or exist independent of service don't become compensable because a screening found them. The VA hasn't issued any guidance specific to this program, and how examiners and raters will treat force-wide hormone data is genuinely unknown. What we're telling you is narrower and more durable: records win claims, this program creates records, and the service members who keep and understand theirs will be in a stronger position than the ones who let the paperwork blow past.
Where we come in
We're a veteran-led firm, and part of our job is watching policies like this one for what they'll mean at claim time, years before the first decision gets appealed. If you're transitioning out with screening results or a TRT history in your file, we represent veterans on initial claims at no charge and can make sure that record gets used properly from day one. And when the VA gets a decision wrong, the appeal is where we live. Either way, reach out, and hang onto those results.











